Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ford

Showing results (981-990 of 1,097) with videos related to

Pageof 110
Sort By:
Plos One|April 18, 2014
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPVLarisa Kizima, Aixa Rodríguez, Jessica Kenney, et al.
Digestive Diseases and Sciences|December 7, 2023
Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver DiseaseJaideep Behari, Allison Bradley, Kevin Townsend, et al.
Foot & Ankle International|October 27, 2024
Initial Safety of Total Talus Replacement Used to Treat Talar Avascular NecrosisBijan Abar, Michael S Kim, Samuel B Adams, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 30, 2023
Safety and Feasibility of a Fast-Track Pathway for Neurosurgical Craniotomy Patients: Bypassing the Intensive Care UnitCarlos Perez-Vega, Devang K Sanghavi, Pablo Moreno Franco, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2012
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFRMahboob Rahman, Charles E Ford, Jeffrey A Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2000
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsP S Dragovich, R Zhou, S E Webber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Journal of Clinical and Translational Science|January 17, 2024
The Trial Innovation Network Liaison Team: building a national clinical and translational community of practiceMarisha E Palm, Dixie D Thompson, Terri Edwards, et al.
The Journal of Biological Chemistry|January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-MetKeith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Journal of AOAC International|September 1, 1996
TCDD residues in fish and shellfish from U.S. waterwaysD Firestone, N V Fehringer, S M Walters, et al.
Pageof 110

Showing results (981-990 of 1,097) with videos related to

Sort By:
Pageof 110
Plos One|April 18, 2014
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPVLarisa Kizima, Aixa Rodríguez, Jessica Kenney, et al.
Digestive Diseases and Sciences|December 7, 2023
Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver DiseaseJaideep Behari, Allison Bradley, Kevin Townsend, et al.
Foot & Ankle International|October 27, 2024
Initial Safety of Total Talus Replacement Used to Treat Talar Avascular NecrosisBijan Abar, Michael S Kim, Samuel B Adams, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 30, 2023
Safety and Feasibility of a Fast-Track Pathway for Neurosurgical Craniotomy Patients: Bypassing the Intensive Care UnitCarlos Perez-Vega, Devang K Sanghavi, Pablo Moreno Franco, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2012
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFRMahboob Rahman, Charles E Ford, Jeffrey A Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2000
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsP S Dragovich, R Zhou, S E Webber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Journal of Clinical and Translational Science|January 17, 2024
The Trial Innovation Network Liaison Team: building a national clinical and translational community of practiceMarisha E Palm, Dixie D Thompson, Terri Edwards, et al.
The Journal of Biological Chemistry|January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-MetKeith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Journal of AOAC International|September 1, 1996
TCDD residues in fish and shellfish from U.S. waterwaysD Firestone, N V Fehringer, S M Walters, et al.
Pageof 110